中文名 | TC-G 1005 |
英文名 | (4-Cyclopropyl-3,4-dihydro-1(2H)-quinoxalinyl)[4-(2,5-dimethylphenoxy)-3-pyridinyl]methanone |
别名 | 化合物TC-G 1005 (4-环丙基-3,4-二氢-1(2H)-喹喔啉基)[4-(2,5-二甲基苯氧基)-3-吡啶基]甲酮 |
英文别名 | TC-G 1005 (4-Cyclopropyl-3,4-dihydro-1(2H)-quinoxalinyl)[4-(2,5-dimethylphenoxy)-3-pyridinyl]methanone Methanone, (4-cyclopropyl-3,4-dihydro-1(2H)-quinoxalinyl)[4-(2,5-dimethylphenoxy)-3-pyridinyl]- |
CAS | 1415407-60-1 |
化学式 | C25H25N3O2 |
分子量 | 399.48 |
密度 | 1.253±0.06 g/cm3(Predicted) |
沸点 | 564.5±50.0 °C(Predicted) |
溶解度 | 溶于DMSO |
酸度系数 | 6.35±0.20(Predicted) |
存储条件 | -20℃ |
产品用途 | TC-G 1005 is a potent and selective TGR5 (GPBAR1) agonist. |
靶点 | IC50: 0.72 nM (hTGR5); 6.2 nM (mTGR5) |
参考资料 展开查看 | 1: Duan H, Ning M, Chen X, Zou Q, Zhang L, Feng Y, Zhang L, Leng Y, Shen J. Design, synthesis, and antidiabetic activity of 4-phenoxynicotinamide and 4-phenoxypyrimidine-5-carboxamide derivatives as potent and orally efficacious TGR5 agonists. J Med Chem. 2012 Dec 13;55(23):10475-89. doi: 10.1021/jm301071h. Epub 2012 Nov 29. PubMed PMID: 23148522. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.503 ml | 12.516 ml | 25.032 ml |
5 mM | 0.501 ml | 2.503 ml | 5.006 ml |
10 mM | 0.25 ml | 1.252 ml | 2.503 ml |
5 mM | 0.05 ml | 0.25 ml | 0.501 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!